Clinical Trial Update: Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

Clinical trial update reporting cerebrospinal fluid levels of erlotinib in patients with stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Lung Cancer | NA | Status: COMPLETED